NewsRoom Articles - Page 1282 of 1389

MondayMar 13, 2017 6:00 pm

NantKwest (NASDAQ: NK) Starts Presentation at 29th Annual ROTH Conference

NantKwest (NASDAQ: NK) is a biotechnology company that engages in the development of immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in phase II clinical trials for the treatment of polyoma virus induced merkel cell carcinoma. It is also developing high-affinity natural killer product candidates primarily for the treatment of solid tumors, breast cancer, multiple myeloma, lymphoma, and…

MondayMar 13, 2017 6:00 pm

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Starts Presentation at 29th Annual ROTH Conference

Madrigal Pharmaceuticals (NASDAQ: MDGL) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapies for the treatment of cardiovascular, metabolic, and liver diseases. The company’s lead candidate is MGL-3196, which has completed Phase I single and multiple dose trials, an orally administered and small-molecule liver-directed selective thyroid hormone receptor-beta agonist for use in the treatment of nonalcoholic steatohepatitis (NASH), and heterozygous and homozygous familial hypercholesterolemia (FH) to lower LDL cholesterol, triglyceride levels, and Lp(a). For more information, visit the company’s website at www.madrigalpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services…

MondayMar 13, 2017 6:00 pm

Wilhelmina International, Inc. (NASDAQ: WHLM) Starts Presentation at 29th Annual Roth Conference

Wilhelmina International (NASDAQ: WHLM) engages in the representation and management of models, entertainers, artists, athletes and other talent to various customers and clients. It offers fashion modeling and talent product-endorsement services to clients, such as advertising agencies, branded consumer goods companies, fashion designers, magazines, retailers, department stores, product catalogs, and Internet sites. The company also provides photography, styling and hair and makeup services to various companies in the retail, pharmaceutical, and music industries; and talent management services. For more information, visit the company’s website at www.wilhelmina.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and…

MondayMar 13, 2017 6:00 pm

Platform Specialty Products Corporation (NYSE: PAH) Starts Presentation at 29th Annual Roth Conference

Platform Specialty Products (NYSE: PAH) produces and sells specialty chemical products in the Americas, the Asia-Pacific and Europe. The Performance Solutions segment offers plating products that are used to plate holes and electroless nickel products. The Agricultural Solutions segment offers fungicides and biofungicides to prevent the spread of fungi and other diseases in crops, herbicides to control unwanted plants, insecticides, bioinsecticides, acaricides, biostimulants, seed treatment products which are applied to seed before planting, innovative nutrition products as well as animal health products such as honey bee protective miticides and veterinary vaccines. For more information, visit the company’s website at www.platformspecialtyproducts.com.…

MondayMar 13, 2017 6:00 pm

LivePerson, Inc. (NASDAQ: LPSN) Starts Presentation at 29th Annual ROTH Conference

LivePerson (NASDAQ: LPSN) provides mobile and online messaging technologies that power digital communication between brands and consumers in the United States, in the United Kingdom, the Asia-Pacific, Latin America and Western Europe. The Business segment facilitates real-time online interactions, such as chat, voice, messaging, and content delivery, across multiple channels and screens for corporations of all sizes. The Consumer segment facilitates online transactions between independent service providers and individual consumers seeking information and knowledge via mobile and online messaging. Its cloud-based platform is LiveEngage, which enables businesses to create a connection with consumers by offering messaging as a preferred channel…

MondayMar 13, 2017 6:00 pm

Depomed, Inc. (NASDAQ: DEPO) Starts Presentation at 29th Annual ROTH Conference

Depomed (NASDAQ: DEPO) is a specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. For more information, visit the company’s website at www.depomed.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and…

MondayMar 13, 2017 6:00 pm

Limbach Holdings, Inc. (NASDAQ: LMB) Starts Presentation at 29th Annual ROTH Conference

Limbach Holdings (NASDAQ: LMB) provides commercial specialty contractor services in the United States. The company provides services in the areas of HVAC (heating, ventilation, and air-conditioning), plumbing, electrical and building controls for the design and construction of new and renovated buildings, as well as maintenance services and equipment upgrades. Its facility services comprise mechanical construction, HVAC service and maintenance, energy audits and retrofits, engineering and design build, constructability evaluation, equipment and materials selection, offsite/prefab construction, and sustainable building solutions and practices. For more information, visit the company’s website at www.limbachinc.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced…

MondayMar 13, 2017 5:30 pm

TransAct Technologies, Inc. (NASDAQ: TACT) Starts Presentation at 29th Annual Roth Conference

TransAct Technologies (NASDAQ: TACT) designs, develops, assembles and markets transaction-based and specialty printers and terminals in the United States and internationally. It offers thermal, inkjet and impact printers and terminals to generate food rotation date and nutritional labels, promotional coupons, and transaction records, such as receipts, tickets, register journals, and other documents, as well as for printed logging and plotting of oil field and drilling data. The company also provides consumable products, including inkjet cartridges, ribbons, receipt papers, color thermal papers, and other printing supplies, as well as replacement parts; maintenance, repair, and testing services; and refurbished printers. For more…

MondayMar 13, 2017 5:30 pm

Fate Therapeutics, Inc. (NASDAQ: FATE) Starts Presentation at 29th Annual ROTH Conference

Fate Therapeutics (NASDAQ: FATE) is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders. The company's hematopoietic cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf product candidates derived from engineered induced pluripotent cell lines, and immuno-regulatory programs. Its adoptive cell therapy programs are based on the company's novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells. Fate Therapeutics is headquartered in San Diego, California. For more information, visit the company’s website at www.fatetherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…

MondayMar 13, 2017 5:30 pm

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) Starts Presentation at 29th Annual ROTH Conference

AcelRx Pharmaceuticals (NASDAQ: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. An NDA for DSUVIA (sufentanil sublingual tablet, 30 mcg) was recently submitted to the FDA for review. The company’s follow on product, ZALVISO® (sufentanil sublingual tablet system), designed for the management of moderate-to-severe acute pain in adult patients in the hospital setting, is currently enrolling patients in a phase 3 clinical trial, IAP312. For more information, visit the company’s website at www.acelrx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NantKwest (NASDAQ: NK) Starts Presentation at 29th Annual ROTH Conference

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Starts Presentation at 29th Annual ROTH Conference

Wilhelmina International, Inc. (NASDAQ: WHLM) Starts Presentation at 29th Annual Roth Conference

Platform Specialty Products Corporation (NYSE: PAH) Starts Presentation at 29th Annual Roth Conference

LivePerson, Inc. (NASDAQ: LPSN) Starts Presentation at 29th Annual ROTH Conference

Depomed, Inc. (NASDAQ: DEPO) Starts Presentation at 29th Annual ROTH Conference

Limbach Holdings, Inc. (NASDAQ: LMB) Starts Presentation at 29th Annual ROTH Conference

TransAct Technologies, Inc. (NASDAQ: TACT) Starts Presentation at 29th Annual Roth Conference

Fate Therapeutics, Inc. (NASDAQ: FATE) Starts Presentation at 29th Annual ROTH Conference

AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) Starts Presentation at 29th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search